Raloxifene reduced vertebral fractures and breast cancer regardless of prior hormone therapy use in womenRaloxifene reduces risk of vertebral fractures and breast cancer in postmenopausal women regardless of prior hormone therapy.

Crandall, Carolyn MD, MS, FACP (commentator)
Johnell, O
Cauley, JA
Kulkarni, PM
et al,

Los Angeles, California, USA

Johnell O, Cauley JA, Kulkarni PM, et al. Raloxifene reduces risk of vertebral fractures and breast cancer in postmenopausal women regardless of prior hormone therapy. J Fam Pract 2004; 53: 789–96.JohnellOCauleyJAKulkarniPMet alRaloxifene reduces risk of vertebral fractures and breast cancer in postmenopausal women regardless of prior hormone therapy.J Fam Pract200453789-96Q In postmenopausal women with osteoporosis, does previous hormone therapy (HT) influence the effect of raloxifene on the risk of vertebral fractures and breast cancer?

For correspondence: Dr O Johnell, Universitetssjukhuset MAS, Malmo, Sweden. [email protected]

Source of funding: none stated.

Evidence Based Medicine 10(3):p 84, June 2005.

Clinical impact ratings GP/FP/Primary care ★★★★★★☆ IM/Ambulatory care ★★★★★☆☆ Gynaecology ★★★★★★☆ Oncology ★★★★★★☆ Endocrine ★★★★★★☆